Development and Validation of a Novel Hepato-Metabolic-Renal Score Nomogram for Predicting Disease-Free Survival in Head and Neck Squamous Cell Carcinoma - Scorecard - MDSpire
Advertisement
Development and Validation of a Novel Hepato-Metabolic-Renal Score Nomogram for Predicting Disease-Free Survival in Head and Neck Squamous Cell Carcinoma
Clinical Scorecard: Creation and Assessment of an Innovative Hepato-Metabolic-Renal Score Nomogram for Forecasting Disease-Free Survival in Patients with Head and Neck Squamous Cell Carcinoma
At a Glance
Category
Detail
Condition
Head and Neck Squamous Cell Carcinoma (HNSCC)
Key Mechanisms
Integrative physiological score based on preoperative laboratory parameters
Target Population
Surgical patients with Head and Neck Squamous Cell Carcinoma
Care Setting
Single-center surgical oncology
Key Highlights
Development of the Hepato-Metabolic-Renal Score (HMRS) from 11 preoperative laboratory parameters
Significant prognostic value for disease-free survival (DFS) demonstrated in both training and validation cohorts
Nomogram showed excellent discrimination and good calibration for predicting DFS
Positive net benefit observed in decision curve analysis
Consistent performance across clinical subsets confirmed
Guideline-Based Recommendations
Diagnosis
Utilize HMRS for prognostic assessment in surgical HNSCC patients
Management
Incorporate HMRS into clinical decision-making for personalized recurrence risk estimation
Monitoring & Follow-up
Regularly assess disease-free survival using the HMRS in follow-up care
Risks
Consider the heterogeneity in DFS when interpreting HMRS results
Patient & Prescribing Data
321 surgical HNSCC patients
HMRS can guide treatment strategies by predicting recurrence risk
Clinical Best Practices
Integrate HMRS into preoperative assessments for surgical HNSCC patients
Use the nomogram for personalized patient management and follow-up
Perform subgroup analyses to ensure consistent application across diverse patient groups
